CompletedNot Applicable

The Effect of Inspiratory Muscle Training on Breast Cancer Patients Undergoing Surgery

Saudi Arabia47 participantsStarted 2023-10-17

Plain-language summary

This study will address the female patients who are exposed to surgery after breast cancer. strength training for the inspiratory muscles will be applied in addition to the traditional care including physical therapy that will be compared to the effect of the traditional care alone on multiple outcome measures such as muscle strength, function, fatigue, and stress.

Who can participate

Age range40 Years – 70 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Post-operative breast cancer female patients * Age ≥40 years * All patients with Eastern Cooperative Oncology Group performance status score ≤ 2 * Having to undergo primary treatment with surgery Exclusion Criteria: * Severe anemia (Hb ≤ 8 g/dL) * Presence of underlying chronic cardiac or respiratory disease * severe infection, neurologic or muscular diseases prohibiting physical activity * uncontrolled and/or extensive brain metastases, or bone metastases that were assessed to pose a risk of pathological fractures from exercising * Contraindications descriped by the physician

What they're measuring

Inspiratory muscle strength by Maximal inspiratory pressure MIP

Timeframe: at baseline

Inspiratory muscle strength by Maximal inspiratory pressure MIP

Timeframe: after the end of the treatment (after 8 weeks)

Inspiratory muscle strength by Maximal inspiratory pressure MIP

Timeframe: at follow up (3 months after the end of the treatment)

Functional exercise capacity evaluated by a 6-minute walk test (6MWT).

Timeframe: baseline

Functional exercise capacity evaluated by a 6-minute walk test (6MWT).

Timeframe: after the end of the treatment (after 8 weeks)

Functional exercise capacity evaluated by a 6-minute walk test (6MWT).

Timeframe: at follow up (3 months after the end of the treatment)

Handgrip strength

Timeframe: at baseline

Handgrip strength

Timeframe: after the end of the treatment (after 8 weeks)

Trial details

NCT IDNCT06091696

SponsorUniversity of Hail

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-01-01

View on ClinicalTrials.gov More Post-operative Breast Cancer trials

Plain-language summary

Who can participate

Age range40 Years – 70 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

What they're measuring

Inspiratory muscle strength by Maximal inspiratory pressure MIP

Timeframe: at baseline

Inspiratory muscle strength by Maximal inspiratory pressure MIP

Timeframe: after the end of the treatment (after 8 weeks)

Inspiratory muscle strength by Maximal inspiratory pressure MIP

Timeframe: at follow up (3 months after the end of the treatment)

Functional exercise capacity evaluated by a 6-minute walk test (6MWT).

Timeframe: baseline

Functional exercise capacity evaluated by a 6-minute walk test (6MWT).

Timeframe: after the end of the treatment (after 8 weeks)

Functional exercise capacity evaluated by a 6-minute walk test (6MWT).

Timeframe: at follow up (3 months after the end of the treatment)

Handgrip strength

Timeframe: at baseline

Handgrip strength

Timeframe: after the end of the treatment (after 8 weeks)